ArticleCureus2026
Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome in a Polymedicated Patient With Osteomyelitis: A Diagnostic Challenge.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Drug reaction with eosinophilia and systemic symptoms (DRESS) is a rare but serious drug reaction that can be life-threatening. This report reviews a case of a male in his 30s with a history of extensive burn injuries, osteomyelitis, and bipolar disorder who was admitted to the hospital for left foot osteomyelitis after failing home intravenous (IV) piperacillin-tazobactam treatment. On hospital day 4, the patient began to develop a progressive macular rash. Laboratory results were significant for worsening transaminitis and elevated eosinophil levels, concerning for DRESS. Active inpatient medications included aripiprazole, lamotrigine, vancomycin, and meropenem. Lamotrigine and all antibiotics were discontinued in the setting of suspected DRESS. Treatment was initiated with IV methylprednisolone 175 mg daily, with a taper over eight to 12 weeks, and an infusion of N-acetylcysteine for liver injury, with eventual improvement of liver enzymes to baseline and resolution of eosinophilia. This case underscores the importance of prompt recognition of DRESS in patients with polypharmacy and complex infectious disease management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.